CMMB stock

Chemomab Therapeutics Ltd DRC (CMMB) financials · $22.2M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Chemomab Therapeutics Ltd DRC (CMMB) $22.2M cap.

Cached annual income statement
LineFY2025FY2024
Cost of Revenue$2.33M$2.46M
Operating Income-$112.0M-$103.0M
Net Income-$8.99M-$13.9M
EPS (Diluted)$0.02$0.04
Cached annual balance sheet
LineFY2025FY2024
Total Assets$13.8M$17.0M
Current Assets$13.4M$16.0M
Cash & Equivalents$7.56M$6.07M
PP&E$176.0K$250.0K
Total Liabilities$1.48M$3.43M
Current Liabilities$1.48M$3.22M
Shareholders' Equity$12.3M$13.5M
Retained Earnings-$111.6M-$102.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$11.1M-$15.4M
CapEx$3.00KN/A
Investing Cash Flow$5.39M$2.30M
Financing Cash Flow$7.16M$9.87M
Net Change in Cash$1.42M-$3.22M
Free Cash Flow-$11.1M-$15.4M
These statements as JSON? API free 100/day

FAQ

What is CMMB P/E and revenue?

Chemomab Therapeutics Ltd DRC (CMMB) $22.2M cap.

What is CMMB revenue?

CMMB income-statement cache has no revenue figure yet.

Is CMMB profitable?

Chemomab Therapeutics Ltd DRC last cached net income is -$8.99M (FY2025).

What are CMMB total assets?

Chemomab Therapeutics Ltd DRC last cached total assets are $13.8M (FY2025).

What is CMMB free cash flow?

Chemomab Therapeutics Ltd DRC last cached free cash flow is -$11.1M (FY2025).

Not investment advice. Cached statements, not a live tape.